(Q40469520)

20 September 2017

1 reference

title

Neuropsychiatric manifestations of systemic lupus erythematosus. (English)

1 reference

20 September 2017

Calabrese LV

1

1 reference

PubMed ID

7652137

20 September 2017

Stern TA

series ordinal

2

1 reference

20 September 2017

1 July 1995

1 reference

20 September 2017

1 reference

20 September 2017

36

1 reference

20 September 2017

344-359

1 reference

20 September 2017

4

1 reference

Central nervous system in acute disseminate lupus erythematosus

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Headache in patients with systemic lupus erythematosus: clinical and telethermographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Aseptic meningitis in systemic lupus erythematosus. Report of three cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Is neurological disease with positive lupus serology sufficient for a diagnosis of systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The neurological manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Nervous system involvement in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Central nervous system involvement in SLE. Diagnostic profile and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Late onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

EPIDEMIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS: TIME TREND AND RACIAL DIFFERENCES

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Carbamazepine-Induced Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Possible induction of systemic lupus erythematosus by valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Laboratory Criteria for a Diagnosis of Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Commentary and update: serological tests for diagnosis of systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The Occurrence of Psychiatric Illness in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

psychiatric symptoms in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Psychoses associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Psychoses in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Psychological factors associated with disseminated lupus erythematosus and effects of cortisone and ACTH

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Disseminated lupus erythematosus; analysis of thirty-four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The study of the psychiatric symptoms of systemic lupus erythematosus.. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Psychopathology associated with systemic lupus erythematosus: a methodological review.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Psychopathology in systemic lupus erythematosus. I. Psychiatric observations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Neuropathologic findings in disseminated lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Central nervous system involvement in systemic lupus erythematosus. A study of 150 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The Choroid Plexus in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cerebral Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The choroid plexus in CNS involvement of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Central nervous system disease in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Serologic Studies In Patients With Systemic Lupus Erythematosus And Central Nervous System Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Neuronal antibodies and cognitive function in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cognitive impairment and autoantibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Autoantibodies in central nervous system lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Editorial: Treatment of central nervous system lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Computed tomography of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cranial computed tomography in the diagnosis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Basal ganglia calcifications in central nervous system lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Solitary paraventricular calcification in cerebral lupus erythematosus: A report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cerebral blood flow variations in CNS lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Positron emission tomography in neuropsychiatric lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cerebritis in lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Cognitive effects of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Neurobehavioral presentations of the antiphospholipid antibody syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Witchcraft and Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

ECT for depression caused by lupus cerebritis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Systemic Lupus Erythematosus with Central Nervous System Involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

ECT for depressed patients with lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

The natural history of systemic lupus erythematosus by prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2895%2971644-9

7 January 2021

10.1016/S0033-3182(95)71644-9

Identifiers

DOI

0 references

PubMed ID

7652137

1 reference

PubMed ID

7652137